Pressure BioSciences, Inc. (OTCMKTS:PBIO – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.24 and traded as low as $0.12. Pressure BioSciences shares last traded at $0.14, with a volume of 66,169 shares trading hands.
Pressure BioSciences Stock Performance
The firm’s 50 day moving average is $0.19 and its two-hundred day moving average is $0.24.
Pressure BioSciences (OTCMKTS:PBIO – Get Free Report) last posted its earnings results on Friday, June 7th. The company reported ($0.30) earnings per share for the quarter. The business had revenue of $0.31 million for the quarter.
Pressure BioSciences Company Profile
Pressure BioSciences, Inc develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.
Recommended Stories
- Five stocks we like better than Pressure BioSciences
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 7/1 – 7/5
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- 3 Stocks to Consider Buying in October
- Qualcomm Stock Continues to Rise in the Face of Negative News
Receive News & Ratings for Pressure BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.
